2.4. Study endpoint

KF Koichi Furui
IM Itsuro Morishima
YM Yasuhiro Morita
YK Yasunori Kanzaki
KT Kensuke Takagi
RY Ruka Yoshida
HN Hiroaki Nagai
NW Naoki Watanabe
NY Naoki Yoshioka
RY Ryota Yamauchi
HT Hideyuki Tsuboi
TM Toyoaki Murohara
ask Ask a question
Favorite

The study endpoint was the recurrence of any documented episode of atrial tachyarrhythmia lasting >30 s with or without the use of antiarrhythmic drugs. We defined 90 days after the patient's last AF ablation procedure as the blanking period. However, if repeated ablation was performed within 90 days after the last session, the patient was considered to have recurrent arrhythmia at day 91.

Do you have any questions about this protocol?

Post your question to gather feedback from the community. We will also invite the authors of this article to respond.

post Post a Question
0 Q&A